Symbols, Analysts, Keywords CREATE FREE ACCOUNT LOG IN

Home Invest with confidence. Gain unlimited access to Premium content now »

Stock Analysis

Market News Give yourself the best tools to

Home Stock Ideas Long Ideas Healthcare
win
Market Data

Dividends

ETFs
Harrow's Drug Iheezo Is Off To A Get research and analysis on your
investments with Seeking Alpha

Education Great Start Premium. You’ll get both the bull and
bear perspective on 1000s of stocks,
Podcasts not just the trending tickers. Join the
Feb. 19, 2024 9:30 AM ET | Harrow, Inc. (HROW) Stock
world’s leading investor
Michigan Value Investor community - and secure your
INVESTING GROUPS Follow
Investing Group Leader
competitive advantage.
Explore Investing Groups

Summary
PORTFOLIOS
Harrow Inc. is leveraging its existing customer base in the
Create Portfolio
compounded ophthalmic pharmaceutical products business to expand
About Portfolio
into branded pharmaceuticals.

FIND & COMPARE

Continue Reading
Stock Screener

ETF Screener

Comparisons
Get alerts on

SUBSCRIPTIONS
HROW - Harrow, Inc.

Alpha Picks Follow 2.16K Followers

Premium & Pro Start now

Group Subscriptions

Recommended For You

Create Free Account
About HROW Stock
How I Would Invest $1,000,000 And Live Off Dividends Forever
Symbol Last Price % Chg
Millennial Dividends
HROW 10.67 -3.87%

1D 5D 1M 6M 1Y 5Y 10Y
Harrow: Hedge Downside Risk With The 11.5% Yielding Baby Bonds
12
Pacifica Yield

11
Applied Optoelectronics Set To Benefit From Increased Demand In Bandwidth
For AI Applications
10
Alan Sumler
Fe… Feb 13 Feb 14 Feb 15 Feb 16

Market Cap $374.71M

Humana, We Have A Problem
Brad Thomas PE -

Yield (TTM) -
3 Stocks I Can't Wait To Buy On A Dip
Rev Growth (YoY) 29.07%
Bradley Guichard
Short Interest -

Warning: Don't Be Lazy With Your Retirement Portfolio Prev. Close $11.10
Rida Morwa

Compare to Peers
Nvidia: The Market Is Wrong
Bohdan Kucheriavyi

Applied Optoelectronics: A Risky Play At A Premium More on HROW

Mauro Solis Vazquez Mellado, CFA
Harrow: Hedge Downside
Risk With The 11.5%
Preferreds Weekly Review: A High Yield-To-Call Is Not Enough Yielding Baby Bonds
ADS Analytics Pacifica Yield

Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity Harrow: Temporary
Avisol Capital Partners Disruption In Stock Price
Creates Excellent
Opportunity
Avisol Capital Partners

Harrow says dry eye drug

Vevye now available in US

Despite Q3 Earnings Miss,

Harrow Is Still Appealing
For 2024
Navigate the Stock Market with Enter email address Sign in with Google
Rational Expectations
Seeking Alpha
Create Free Account or Sign in with Apple
Create a free account to continue.
Already a member? Sign in I agree to Terms of Use & Privacy Policy. Trending Analysis
Sign in with Facebook

3 Stocks I Can't Wait To Buy

On A Dip

Our Top 10 Dividend Growth

Stocks - February 2024

Wall Street Brunch: Nvidia -

That's It

Nvidia Q4 Preview: A Post-

Earnings Correction Can Be
A Buy Opportunity

Harness The Power Of

Compounding With These
Time-Tested CEFs

See All Analysis »

Trending News
Is the stock market open on
1
Presidents' Day?

Earnings for U.S. companies

2
saw 5% y-o-y growth during
Q4, says JPM

Goldman jumps on the

3
Magnificent 7 earnings
bandwagon

Weight-loss drugs cut

4
grocery bills by up to 9% -
Morgan Stanley

Earnings week ahead:

5
NVIDIA, Walmart, Home
Depot, Lucid and more

See All News »

FOLLOW US DOWNLOAD APP

Power to Investors

Subscription Support: 1-347-509-6837 RSS Feed Sitemap Group Subscriptions Affiliate Program About Us Careers Contact Us

ACCOUNT STOCK ANALYSIS ANALYSIS BY SECTOR MARKET OUTLOOK MARKET NEWS

Account Login Stock Ideas Energy Today's Market Top News

Create Portfolio Long Ideas Communication Services Economy Trending News

Manage My Portfolio Stock Upgrades & Downgrades Real Estate Gold & Precious Metals On the Move
Privacy Editors' Picks Consumer Staples Commodities Market Pulse

Alert Preferences Quick Picks & Lists Tech Forex Global Markets

Emerging Markets Basic Materials Editors' Picks Notable Calls

SUBSCRIPTIONS
Healthcare Cryptocurrency Buybacks
STOCK SCREENER
Premium & Pro Consumer Commodities
MARKET DATA
Group Subscriptions Stocks by Quant Utilities Cryptocurrency
Alpha Picks Top Stocks Financials Bond ETFs Debt/Share Issuance
Top Quant Dividend Stocks Industrials Commodity ETFs Dividends - Stocks
INVESTING GROUPS
High Dividend Yield Stocks Country ETFs Dividends - Funds
STOCK COMPARISON TOOLS
Most Popular Top Dividend Stocks Currency ETFs Guidance
Free Trials FAANG Stocks Dividend ETFs IPOs
ETFS & FUNDS
Top Rated Gold ETFs Emerging Market ETFs SPACs
Dividend Investing ETF Screener Cash Equivalents Global and Regional ETFs Politics
Value Investing ETF Analysis Big Bank Stocks Growth vs. Value ETFs M&A
Options Trading ETF Guide Big Pharma Stocks Market Cap ETFs US Economy
Growth Stocks Mutual Funds Retail Stocks Real Estate ETFs Wall Street Breakfast
Biotech Investing Closed End Funds Sector ETFs
TOP INDEXES NEWS BY SECTOR
Tech Stocks Editors' Picks ETF Strategies
Quantitative Investing Dow Jones Smart Beta Consumer
DIVIDENDS
S&P 500 Themes & Subsectors ETFs Energy
LEARN
Dividend Stock News Nasdaq Cryptocurrency Financials
Investing Education REITs Gold Healthcare
Investing Strategies Dividend Ideas Bitcoin Tech
Retirement Investing Dividend Strategy
EARNINGS
Stock Market Sectors Dividend Quick Picks

Stock Market Holidays & Hours Editors' Picks Earnings Calendar

After Hours Trading Earnings News
Portfolio Management Earnings Analysis
Cryptocurrency Earnings Calls Transcripts
Dividend Investing

Portfolio Strategy

Fixed Income
Retirement

IPO's

Podcasts
Editors' Picks

Terms Of Use Privacy Do Not Sell My Personal Information Market Data Sources © 2024 Seeking Alpha